Letter to the Editor June 1, 2004

Venlafaxine XR and Chronic Pelvic Pain Syndrome

Jordan F. Karp, MD

J Clin Psychiatry 2004;65(6):880-881

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Venlafaxine, a selective serotonin and norepinephrine reuptake inhibitor (SNRI), has been shown to have analgesic effects in neuropathic1-3 and postsurgical pain4 and in pain and uncomfortable physical symptoms associated with premenstrual dysphoric disorder.5 This agent has also been reported to both prevent and resolve hyperalgesia in rats with experimentally produced painful neuropathic lesions.6